Clinical Trials Directory

Trials / Completed

CompletedNCT03865355

Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients

Unique Blood and CSF Metabolic Profile Association With Gliomas in Adults

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Novosibirsk State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is an exploratory, non-interventional and translational clinical study. The aim of this study is to analyze blood and cerebrospinal fluid metabolomic profile in glioma patients.

Detailed description

The analysis of metabolic profile in the plasma and CSF could become the new less invasive approach in the establishing diagnosis as well as an important prognostic factor in patients with glioma. The researches will assess the blood and CSF metabolic profile in patients with different types of gliomas as well as in patient without ones. This can help to find new biomarkers for low- and high-grade gliomas correlating with patient outcomes. Blood and CSF samples will be collected from patients with suspected newly diagnosed low-grade (I-II) or high-grade (III-IV) gliomas as well as from patients who have hospitalized for reconstructive surgery after craniofacial trauma. All samples will be collected before any surgical intervention and at various follow-up time points until progression or death. The results of the study are planned to be translated into the hospital setting as support to other diagnostics procedures and to the differential diagnosis between glioma grades.

Conditions

Interventions

TypeNameDescription
OTHERNon- interventionalTranslational, observational study

Timeline

Start date
2019-03-13
Primary completion
2024-04-11
Completion
2024-11-11
First posted
2019-03-06
Last updated
2024-11-14

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT03865355. Inclusion in this directory is not an endorsement.